Brainlab, which earlier this month dealt its orthopedic joint reconstruction assets to Smith & Nephew (NYSE:SNN), is already an investor and markets the Medineering robot-assisted surgical arm under the Cirq brand. The Munich-based company said it plans to fold the Medineering tech into its open-architecture surgery offering.
“Medineering introduced a fresh new approach to surgical robotics when we entered into our partnership less than three years ago,” pesident & CEO Stefan Vilsmeier said in prepared remarks. “Today, we are shifting gears and accelerating development with additional resources to address a broader clinical market.”
“Becoming part of Brainlab means scalability for our technology and improved market access,” added Medineering co-founder & CEO Stephan Nowatschin. “Combining our open platform with the software ecosystem from Brainlab will enable more efficient development of very competitive clinical solutions.”